TOI Oncology Institute, Inc. Insider Trading

10% Owner Chernett Jorey purchases 38,500 shares at $4.07 avg; stock +18.2% in 30d, +60.0% in 90d

Chernett Jorey, a 10% owner, executed 2 separate purchases totaling 38,500 shares for $156,595.00 at a blended average price of $4.07 on 2026-05-19 and 2026-05-20, increasing his holdings from 10.53M to 10.57M shares. The timing of this purchase aligns with a notable price recovery: the stock has risen 18.2% over 30 days and 60.0% over 90 days, and is currently trading at $4.16, only 14.8% below its 52-week high of $4.88. His 5 prior purchases at this ticker all showed positive 90-day returns (+3.2% to +38.5%), establishing a consistent pattern of prior trades that eventually gained. The company reported quarterly revenue of $147.4M with annual growth of +27.8%, though it remains unprofitable with $-2.5M net income in the latest quarter. This buy by a major shareholder during a period of stock appreciation warrants observation given his track record at this ticker.

10% owner Chernett Jorey purchased 30,000 shares of TOI at $4.09 on 2026-05-19; 5 of 5 prior TOI buys showed positive 90d returns

Chernett Jorey, a 10% owner, purchased 30,000 shares at $4.09, bringing holdings to 10,529,358 shares and raising his stake slightly by 30,000 shares. This represents his sixth purchase at TOI over a concentrated period; across his prior five TOI trades, all five generated positive 90-day returns (ranging from +22.4% to +38.5%), indicating a pattern of consistent timing accuracy at this ticker. The company carries meaningful headwinds—it is unprofitable (net income of $-2,492,000 on revenue of $147,441,000) and the stock trades 14.8% below its 52-week high—yet the insider continues to accumulate. The 30-day momentum is strong at +18.2%, and the 90-day move of +60.0% suggests near-term strength, but the transaction's significance derives from whether the insider's historically well-timed pattern at TOI persists and whether an unprofitable but revenue-growing business ($147,441,000 latest quarter, +27.8% annual growth) can narrow losses in the medium term.